Inactive Instrument

SweeGen, Inc. Stock Other OTC

Equities

SWEE

US8703341094

Food Processing

Dynamic Chart
Sweegen's Rebaudioside M Sweetener Technology Receives Regulatory Approval in Taiwan CI
Sweegen, Inc. Announces Growth Capital Investments and Manufacturing Partnership with Sumitomo Chemical Co CI
SweeGen, Inc. announced that it has received funding from Sumitomo Chemical Company, Limited, Pasaca Capital, Inc. CI
Conagen and Sweegen Teams Up to Develop Modern Natural Sweeteners CI
Sweegen’s Signature Stevia Receives Approval in Colombia CI
Sweegen Expands Signature Stevia Footprint in Mexico CI
Sweegen Blazes New Territory in Sugar Reduction with Forward Progress in Brazzein CI
Sweegen Expands Sugar Reduction Portfolio with High-Intensity Sweetener Brazzein CI
Sweegen Announces Premiumization of Low-Calorie Confectionery Chocolate CI
European Union Commission Publishes Approval of Sweegen’S Non-Gmo Signature Bestevia Rebaudioside M (Reb M) for Use in Food and Beverages CI
The Malaysia Ministry of Health Accepts Sweegen?s Zero-Calorie Bestevia Sweeteners, Rebaudiosides D, E and M for Use as Ingredients in Food and Beverage Products CI
SweeGen’s Bestevia Reb M Heads to Final Approval in European Union CI
SweeGen’s Bestevia® Rebaudioside B Receives U.S. FDA GRAS No Objection Letter CI
SweeGen Announces Successful Scale-Up of Bestevia® Reb N CI
SweeGen Announces Approval in Brazil of Full Range of Next Generation Stevia Sweeteners CI
More news
Managers TitleAgeSince
Chief Executive Officer 59 14-12-22
Director of Finance/CFO - -
General Counsel - -
Members of the board TitleAgeSince
Director/Board Member 83 -
More insiders
SweeGen, Inc. is a development-stage company. The Company intends to leverage the experience of its new corporate and scientific management team, which has experience in managing and developing large and small private and public companies; pathway engineering; microbial platform development, and developing and manufacturing food ingredients, biological products, dietary supplements and botanical extracts. The Company focuses on seeking, developing and acquiring, completely or a substantial interest in, companies or assets. The Company's subsidiary is Phytosub, Inc. As of June 30, 2016, the Company had not generated any revenues.
More about the company